A Prospective Study of Dextran-induced Anaphylactoid Reactions in 5745 Patients
Overview
Critical Care
Authors
Affiliations
A prospective study of dextran-induced anaphylactoid reactions (DIAR) in 5745 gynaecological and obstetric patients who received dextran 70 solution intravenously while undergoing major surgery revealed 8 patients who had Grade I or II reactions and 7 patients who had Grade III or IV reactions. The incidence of severe reactions was 1:821 patients treated. The overall incidence of reactions per patient treated was 1:383. One neonatal death followed a dextran-induced cardiac arrest in a woman about to undergo caesarean section. The risks of dextran 70 treatment exceeded the risks of thromboembolism in these patients.
Wang Z, Wang X, Xu W, Li Y, Lai R, Qiu X Pharmaceutics. 2023; 15(11).
PMID: 38004601 PMC: 10674763. DOI: 10.3390/pharmaceutics15112623.
Middleton P, Shepherd E, Gomersall J Cochrane Database Syst Rev. 2021; 3:CD001689.
PMID: 33779986 PMC: 8092635. DOI: 10.1002/14651858.CD001689.pub4.
Sugar-based biopolymers as novel imaging agents for molecular magnetic resonance imaging.
Han Z, Liu G Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019; 11(4):e1551.
PMID: 30666829 PMC: 6579682. DOI: 10.1002/wnan.1551.
Shiratori T, Sato A, Fukuzawa M, Kondo N, Tanno S Case Rep Crit Care. 2015; 2015:967560.
PMID: 26171255 PMC: 4480245. DOI: 10.1155/2015/967560.
Effects of dextran-40 on flap viability after modified radical mastectomy.
Yildiz B, Sulu B Can J Plast Surg. 2014; 21(2):83-6.
PMID: 24431947 PMC: 3891096. DOI: 10.1177/229255031302100207.